MK

Max Klement

Life Science Venture Capital

Greater London, England

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $1,000,000.00

  • Target Investment:

    $500,000.00

Skills

Cell Culture
Fluorescence Microscopy
Confocal Microscopy
Matlab
Microsoft Office
Molecular Biology
Microbiol
Fermentation Technology
Surface Plasmon Resonance
Mammalian Cell Culture
Image Processing
Protein Assays
Protein Purification
HPLC
Affinity Chromatography
Differential Scanning Calorimetry
Flow Cytometry
Technical Writing
AutoCAD
Gel Electrophoresis

Education

Investments

Complement Therapeutics

Seed

Total Funding: $85M

Work Experience

Novo Holdings

2022

  • Principal, Venture Investments

    2022

BGV (BioGeneration Ventures)

2019 - 2022

  • Principal

    2022 - 2022

    Board director at Complement Therapeutics. Board observer at Dualyx, Link Immunotherapeutics, and VarmX.

  • Senior Associate

    2020 - 2021

  • Associate

    2019 - 2020

Eden Biologics

2016 - 2017

  • Project Manager/ Upstream Process Development Scientist

    2016 - 2017

Hummingbird Bioscience

2014 - 2016

  • Project Manager

    2014 - 2016

United Nations ESCAP

2015 - 2015

  • Environment and Development Division

    2015 - 2015

A*STAR - Agency for Science, Technology and Research

2010 - 2014

  • Research Fellow

    2010 - 2014